首页 › 基金 › Logos Global Management LP › ACHV
Logos Global Management LP 对 ACHV 的持仓历史
ACHIEVE LIFE SCIENCE INC · 医疗保健
Logos Global Management LP 在 Q3 2026 的 13F 申报中披露持有 ACHV(ACHIEVE LIFE SCIENCE INC)1,000,000 股,市值约 US$8.1M,约占其申报组合的 0.49%,在其申报持仓中市值排名第 45 位。 Logos Global Management LP 最近 2 个申报季度中有 2 个季度披露了 ACHV 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Logos Global Management LP 对 ACHV 的持仓演变
Logos Global Management LP 于 Q2 2026 首次披露 ACHV 持仓:5,425,000 股(约 US$35.4M)。 在 2 次申报中,Logos Global Management LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,000,000 股、市值约 US$8.1M,环比减持 -4,425,000 股。。 持仓曾出现大幅变动:Q3 2026 减持约 82% (随后一个季度股价下跌 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 5.42M | $35.43M | 新进 |
| Q3 2026 | 1.00M | $8.09M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ACHV 与 13F 数据
ACHV(ACHIEVE LIFE SCIENCE INC)属于医疗保健行业。我们追踪的基金中还有 69 只申报持有 ACHV,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), Paradigm Biocapital Advisors LP (US$40.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ACHV 的基金
- Frazier Life Sciences Management, L.P. 7.61M 股 · $49.72M · Q2 2026
- TPG GP A, LLC 6.88M 股 · $44.91M · Q2 2026
- Paradigm Biocapital Advisors LP 4.95M 股 · $40.06M · Q3 2026
- venBio Partners LLC 5.91M 股 · $38.62M · Q2 2026
- Propel Bio Management, LLC 3.86M 股 · $31.26M · Q3 2026
- Vivo Capital, LLC 2.75M 股 · $22.26M · Q3 2026
- Venrock Adviser, LLC 2.75M 股 · $17.96M · Q2 2026
- Simplify Asset Management Inc. 932.11K 股 · $7.54M · Q3 2026
- Spruce Street Capital LP 736.64K 股 · $5.96M · Q3 2026
- KVP Capital Advisors, LP 462.36K 股 · $3.74M · Q3 2026
- Blue Owl Capital Holdings LP 412.65K 股 · $3.34M · Q3 2026
更多关于 Logos Global Management LP
常见问题
How long has Logos Global Management LP held ACHV?
Logos Global Management LP has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Logos Global Management LP's current position in ACHV?
As of Q3 2026, Logos Global Management LP holds 1.00M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $8.09M, representing 0.49% of its reported portfolio and ranking #45.
Has Logos Global Management LP been buying or selling ACHV?
In the latest 13F filing (Q3 2026), Logos Global Management LP reduced its position in ACHV.
Which other funds hold ACHV?
Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, Paradigm Biocapital Advisors LP, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.